Why Nostr? What is Njump?
2024-06-09 10:06:27

Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares on Nostr: Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares =============== ...

Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares
===============
#decb3279 ver:0.06

Bank of Nova Scotia sells majority of Apellis Pharmaceuticals shares, reducing its position by 97.8%. Other hedge funds also making changes. Insiders actively selling stock. Analysts rate APLS as 'Moderate Buy' with target price of $74.38. Apellis Pharmaceuticals focuses on autoimmune and inflammatory diseases. Market cap of $4.90 billion. Investors should conduct thorough research. #biopharma #investing...

#newstr #ApellisPharmaceuticals #Nasdaq:apls #BankOfNovaScotia #HedgeFunds #AnalystRatings #InsiderTrades #BiopharmaceuticalCompany #TherapeuticCompounds #AutoimmuneDiseases #InflammatoryDiseases #Empaveli #Syfovre #MarketCap #EarningsPerShare #Revenue

https://here.news/story/decb3279?ver=0.06
Author Public Key
npub13ztk8e5ea38l6alas47k2n5sjqjwu3njw4f7n2pzkn3zgvtg3dhsv6qmx0